← All trials
NCT02911298
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 25, 2016
- Primary completion
- Mar 6, 2017
- Completion date
- Mar 6, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Tillotts PharmaLead sponsor
- University of BaselOverall official - principal investigator
- SocraTec R&D GmbHCollaborator
- University of BernCollaborator
- Swiss Commission for Technology and InnovationCollaborator
- University of BaselCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.